patient
abnorm
liver
test
encount
often
assum
liver
primari
culprit
diseas
process
howev
numer
system
ill
diseas
organ
produc
sign
symptom
indistinguish
primari
liver
diseas
hepat
manifest
disord
may
rang
mild
enzym
abnorm
signific
liver
injuri
liver
failur
chapter
review
liver
involv
select
system
disord
heart
diseas
pulmonari
diseas
amyloidosi
connect
tissu
disord
rey
syndrom
jejunoil
bypass
hematolog
disord
system
disord
hepat
involv
sarcoidosi
cystic
fibrosi
sepsi
cover
elsewher
textbook
liver
involv
occur
patient
acut
chronic
heart
diseas
spectrum
rang
asymptomat
increas
liver
biochemistri
fulmin
liver
failur
liver
receiv
signific
portion
cardiac
output
therefor
condit
decreas
cardiac
output
lead
fall
hepat
perfus
liver
abl
compens
chang
hepat
blood
flow
via
vasoact
mechan
increas
oxygen
extract
period
hepat
hypoperfus
howev
critic
level
left
right
heart
failur
reach
hepat
injuri
may
occur
rightsid
heart
failur
suggest
damag
caus
elev
right
atrial
pressur
lead
elev
hepat
venou
pressur
caus
distent
hepat
sinusoid
liver
cell
hypoxia
leftsid
heart
failur
decreas
cardiac
output
result
diminish
hepat
perfus
lead
hepat
hypoxia
gener
term
liver
involv
right
heart
failur
refer
congest
hepatopathi
wherea
liver
injuri
result
left
heart
failur
known
ischem
hepat
howev
two
phenomena
often
coexist
may
indistinguish
clinic
practic
final
common
pathway
liver
damag
appear
centrilobular
zone
iii
hepatocellular
necrosi
portion
liver
lobul
vulner
hypox
injuri
due
organ
liver
acinu
highli
oxygen
blood
enter
hepat
lobul
via
branch
hepat
arteri
portal
vein
periport
region
pass
hepat
sinusoid
toward
termin
hepat
venul
oxygen
extract
hepatocyt
centrilobular
area
perfus
blood
least
well
oxygen
liver
abnorm
patient
right
heart
failur
common
right
heart
failur
isol
due
cor
pulmonal
primari
pulmonari
hypertens
like
consequ
left
ventricular
failur
larg
studi
patient
acut
chronic
right
heart
failur
hepatomegali
present
physic
examin
splenomegali
patient
find
right
heart
failur
peripher
edema
pleural
effus
ascit
also
frequent
present
tabl
ascit
promin
patient
chronic
right
heart
failur
acut
right
heart
failur
characterist
chang
histolog
seen
liver
patient
congest
heart
failur
gross
inspect
congest
liver
appear
enlarg
purpl
blunt
edg
classic
describ
nutmeg
appear
caus
altern
area
pale
normalappear
parenchyma
contrast
congest
hemorrhag
area
correspond
centrilobular
region
liver
figur
microscop
central
vein
sinusoid
centrilobular
region
becom
dilat
engorg
erythrocyt
inflamm
notic
absent
figur
adjac
hepatocyt
may
becom
compress
atrophi
longstand
hepat
congest
fibrosi
cirrhosi
may
develop
cardiac
cirrhosi
figur
hepat
congest
due
right
heart
failur
result
numer
biochem
abnorm
tabl
chronic
congest
section
ix
liver
affect
organ
nonhepat
condit
naga
chalasani
oscar
w
cum
heart
failur
hyperbilirubinema
occur
patient
elev
gener
mild
less
mgdl
compos
predominantli
unconjug
bilirubin
serum
aminotransferas
level
usual
normal
minim
elev
compens
chronic
congest
heart
failur
may
becom
elev
exacerb
heart
failur
prothrombin
time
prolong
major
patient
hepat
congest
right
heart
failur
patient
anticoagul
warfarin
sodium
warfarin
dilat
cardiomyopathi
may
decreas
warfarin
requir
exacerb
congest
heart
failur
effect
appreci
could
result
danger
prolong
prothrombin
time
hepat
biochem
abnorm
gener
improv
improv
cardiac
function
sever
sign
symptom
congest
heart
failur
eg
ascit
pedal
edema
mild
hyperbilirubinemia
also
seen
patient
decompens
hepat
cirrhosi
distinguish
two
entiti
may
difficult
patient
particularli
difficult
distinguish
cardiac
ascit
cirrhot
ascit
clinic
case
character
ascit
fluid
measur
hepat
venou
pressur
gradient
may
assist
prospect
studi
patient
cardiac
ascit
serum
ascit
albumin
concentr
gradient
gdl
total
protein
gdl
addit
cardiac
ascit
significantli
ascit
fluid
red
cell
count
higher
level
lactat
dehydrogenas
ischem
hepat
defin
hepatocellular
necrosi
associ
decreas
hepat
perfus
rel
infrequ
report
incid
hospit
patient
affect
age
group
although
frequent
report
older
popul
undoubtedli
reflect
increas
risk
underli
cardiovascular
diseas
older
peopl
seen
children
often
associ
congenit
heart
diseas
overwhelm
sepsi
term
ischem
hepat
misnom
ischem
liver
injuri
character
centrilobular
necrosi
absenc
inflamm
diagnosi
ischem
hepat
consid
patient
elev
liver
enzym
aspart
aminotransferas
ast
alanin
aminotransferas
alt
lactat
dehydrogenas
ldh
set
document
suspect
system
hypotens
liver
highli
vascular
organ
receiv
approxim
cardiac
output
seventi
percent
hepat
blood
flow
deriv
portal
system
deliv
hepat
arteri
liver
arteri
perfus
express
linear
relat
blood
pressur
blood
flow
liver
maintain
normal
oxygen
uptak
increas
oxygen
extract
much
oxygen
blood
extract
singl
pass
liver
remark
compensatori
mechan
like
account
low
incid
liver
damag
shock
resist
ischemia
nevertheless
compensatori
mechan
overwhelm
patient
sever
diminish
hepat
perfus
lead
ischem
liver
injuri
cardiogen
shock
caus
eg
myocardi
infarct
tamponad
commonli
report
risk
factor
develop
ischem
hepat
transient
decreas
cardiac
output
seen
patient
arrhythmia
valvular
heart
diseas
may
also
result
hepat
injuri
even
absenc
bona
fide
hypotens
rel
hypotens
episod
hypotens
result
ischem
hepat
may
brief
sometim
may
document
episod
hypotens
although
diminish
hepat
perfus
system
hypotens
either
absolut
rel
essenti
recent
studi
suggest
system
hypotens
shock
alon
insuffici
caus
ischem
hepat
studi
patient
ischem
hepat
compar
control
group
consist
previous
healthi
subject
major
nonhepat
trauma
mark
hypotens
mean
systol
pressur
mmhg
last
mean
minut
patient
ischem
hepat
organ
heart
diseas
demonstr
right
heart
failur
none
subject
control
group
develop
ischem
hepat
despit
profound
hypotens
find
suggest
right
heart
failur
passiv
hepat
congest
render
liver
suscept
ischem
liver
injuri
transient
system
hypotens
henrion
et
al
recent
publish
paper
describ
clinic
hemodynam
featur
episod
ischem
hepat
ischem
hepat
occur
patient
congest
heart
failur
acut
heart
failur
hepat
hypoxia
result
primarili
decreas
hepat
blood
flow
venou
congest
howev
ischem
hepat
occur
patient
toxic
septic
shock
oxygen
deliveri
liver
decreas
oxygen
need
increas
lead
hepat
hypoxia
noncardiogen
caus
ischem
hepat
includ
hypovolem
shock
hemorrhag
dehydr
heat
stroke
septic
shock
rare
episod
ischem
hepat
report
patient
ingest
vasoact
medic
ergotamin
overdos
protract
seizur
children
clinic
pictur
usual
domin
cardiovascular
septic
hemorrhag
ill
precipit
hepat
hypoperfus
distinct
biochem
pattern
characterist
disord
serum
aminotransferas
level
rise
rapidli
ischem
episod
peak
within
day
figur
treatment
underli
ill
serum
aminotransferas
usual
return
nearnorm
within
day
initi
insult
persist
elev
serum
aminotransferas
level
beyond
period
impli
poor
prognosi
due
continu
hepat
hypoperfus
serum
alt
ast
activ
strikingli
elev
may
exceed
time
upper
limit
normal
figur
less
mark
elev
ul
also
report
biopsyproven
ischem
hepat
serum
ldh
activ
also
markedli
elev
patient
ischem
hepat
fraction
serum
ldh
activ
mostli
hepat
origin
level
ldh
may
rise
time
upper
limit
normal
parallel
pattern
aminotransferas
activ
brisk
rise
rapid
resolut
note
serum
ldh
usual
slightli
elev
patient
acut
viral
hepat
mark
elev
alkalin
phosphatas
serum
bilirubin
unusu
ischem
hepat
cholestasi
demonstr
liver
biopsi
patient
mild
elev
serum
bilirubin
may
seen
rare
exce
four
time
upper
limit
normal
one
seri
patient
ischem
hepat
addit
biochem
featur
note
might
help
diagnosi
patient
seri
transient
abnorm
serum
creatinin
blood
urea
nitrogen
chang
sometim
mark
consist
acut
renal
failur
resolv
day
author
specul
hypotens
insult
liver
similar
advers
effect
kidney
hyper
glycemia
hypoglycemia
seen
one
seri
twothird
patient
ischem
hepat
newonset
hyperglycemia
occur
within
hour
ill
anoth
report
hypoglycemia
seen
patient
ischem
hepat
histolog
studi
ischem
hepat
limit
patient
diagnosi
ischem
hepat
consid
usual
critic
ill
often
multiorgan
failur
make
liver
biopsi
impract
nevertheless
hallmark
ischem
hepat
centrilobular
necrosi
absenc
inflammatori
infiltr
gibson
dudley
studi
patient
characterist
histolog
find
conclud
diagnosi
ischem
hepat
could
made
without
liver
biopsi
appropri
clinic
set
patient
potenti
caus
fall
cardiac
output
rapid
rise
level
serum
aminotransferas
ldh
primari
liver
diseas
give
mark
elev
serum
aminotransferas
follow
rapid
resolut
diagnosi
ischem
hepat
made
readili
patient
intens
care
unit
rapid
strike
increas
serum
aminotransferas
ldh
activ
recent
suffer
document
acut
hypotens
episod
requir
pressor
support
acut
viral
hepat
may
mimic
clinic
pictur
seen
ischem
hepat
viral
hepat
usual
accompani
symptomat
prodrom
histori
exposur
infecti
agent
serolog
help
exclud
viral
etiolog
serum
ldh
activ
mildli
elev
viral
hepat
patient
modest
elev
serum
aminotransferas
chronic
hepat
b
hepat
c
exclud
histori
appropri
serolog
test
examin
previou
liver
enzym
result
prior
current
ill
may
invalu
distinguish
acut
ill
chronic
viral
hepat
special
care
taken
identifi
medic
taken
patient
prior
admiss
well
start
sinc
hospit
drug
hepatox
associ
strike
elev
serum
aminotransferas
ldh
activ
acetaminophen
toxic
alway
consid
patient
mark
elev
serum
aminotransferas
level
renal
insuffici
amiodaron
antiarrhythm
agent
increasingli
use
manag
unstabl
tachyarrhythmia
toxic
also
consid
differenti
diagnosi
sever
case
acut
hepat
fulmin
liver
failur
report
intraven
load
dose
amiodaron
caus
mark
acut
elev
serum
ast
activ
includ
rhabdomyolysi
acut
myocardi
infarct
acut
cholang
hepat
trauma
hepat
infarct
distinguish
ischem
hepat
histori
addit
laboratori
investig
treatment
ischem
hepat
direct
underli
ill
therapi
improv
cardiac
output
inotrop
pressor
improv
hepat
perfus
result
resolut
ischem
hepat
similarli
volum
resuscit
patient
hemorrhag
shock
appropri
treatment
septic
shock
indirectli
improv
cardiac
output
hepat
perfus
special
consider
given
prescrib
medic
patient
circulatori
failur
ischem
hepat
clearanc
certain
medic
eg
lidocain
calciumchannel
blocker
depend
hepat
blood
flow
clearanc
greatli
diminish
set
inde
associ
report
use
calciumchannel
blocker
antiarrhythm
agent
patient
ischem
hepat
increas
mortal
although
clear
studi
wors
prognosi
mere
relat
presenc
sever
cardiac
diseas
opiat
analges
often
prescrib
critic
ill
patient
also
potenti
accumul
caus
neurolog
respiratori
depress
suggest
risk
acetaminophen
toxic
increas
patient
underli
cardiomyopathi
even
low
dose
absenc
alcohol
ingest
prognosi
ischem
hepat
larg
depend
upon
prognosi
underli
ill
shortterm
mortal
report
high
patient
ischem
hepat
onemonth
surviv
rate
patient
ischem
hepat
seri
henrion
et
al
respect
howev
despit
massiv
hepat
necrosi
may
occur
death
due
hepat
failur
extrem
rare
caus
death
usual
result
poor
cardiac
reserv
aminotransferas
level
seem
prognost
signific
stratifi
accord
peak
ast
activ
surviv
patient
ast
level
lower
iul
compar
patient
peak
ast
activ
valu
pattern
ast
activ
howev
seem
prognost
valu
patient
ischem
hepat
die
level
serum
ast
drop
appreci
peak
valu
surviv
ast
level
rapidli
return
toward
normal
suggest
improv
cardiac
function
constrict
pericard
may
masquerad
primari
liver
diseas
pulsatil
hepatomegali
splenomegali
ascit
often
present
patient
constrict
pericard
import
physic
find
includ
elev
jugular
venou
pressur
pulsu
paradoxu
pericardi
knock
note
ascit
promin
pedal
edema
histolog
featur
usual
nonspecif
diffus
centrilobular
congest
necrosi
fibrosi
common
may
mild
abnorm
patchi
fibrosi
without
congest
occasion
promin
sinusoid
dilat
hemorrhag
necrosi
hepat
vein
thrombosi
lead
misdiagnosi
buddchiari
syndrom
tuberculosi
remain
import
caus
constrict
pericard
etiolog
cardiac
surgeri
connect
tissu
disord
subclin
viral
pericard
malign
becom
increasingli
frequent
pericardi
calcif
chest
radiographi
low
voltag
electrocardiographi
present
suggest
constrict
pericard
recent
report
indic
pericardiectomi
improv
liver
function
assess
indocyanin
green
clearanc
patient
liver
injuri
caus
constrict
pericard
although
case
ischem
hepat
relat
alter
hepat
perfus
eg
congest
heart
failur
clear
sever
arteri
hypoxemia
caus
sever
respiratori
diseas
also
lead
hepat
injuri
independ
hepat
perfus
abnorm
hypox
hepat
recent
studi
investig
detail
hemodynam
oxygen
transport
abnorm
consecut
episod
hypox
hepat
caus
acut
exacerb
chronic
respiratori
failur
without
left
heart
failur
patient
mark
arteri
hypoxemia
mean
pao
mmhg
paco
mmhg
elev
central
venou
pressur
elev
cardiac
index
low
system
vascular
resist
oxygen
deliveri
significantli
decreas
patient
despit
reason
hepat
blood
flow
measur
lowdos
galactos
clearanc
test
author
suggest
hypox
hepat
induc
acut
exacerb
chronic
respiratori
failur
due
sever
arteri
hypoxemia
background
elev
central
venou
pressur
passiv
hepat
congest
patient
hypox
hepat
caus
respiratori
diseas
accompani
cardiac
dysfunct
howev
report
sever
obstruct
sleep
apnea
osa
lead
hypox
hepat
absenc
cardiac
dysfunct
recent
studi
suggest
chronic
intermitt
hypoxemia
may
caus
chronic
lowgrad
hepat
injuri
patient
osa
chin
et
al
investig
relationship
liver
enzym
abnorm
intermitt
hypoxemia
obes
men
osa
studi
preval
unexplain
elev
transaminas
obes
patient
osa
interestingli
author
systemat
evalu
effect
treatment
nasal
continu
posit
airway
pressur
cpap
level
aminotransferas
insulin
glucos
obes
subject
osa
signific
decreas
level
transaminas
overnight
month
month
nasal
cpap
treatment
signific
chang
degre
insulin
resist
tabl
jejunoil
bypass
surgeri
introduc
surgic
treatment
morbid
obes
initi
enthusiasm
radic
weightloss
procedur
temper
recognit
myriad
associ
complic
includ
electrolyt
abnorm
kidney
problem
gallston
sever
malnutrit
liver
diseas
hepat
effect
jejunoil
bypass
includ
fatti
infiltr
cirrhosi
progress
liver
failur
procedur
rare
ever
perform
today
new
diagnos
liver
diseas
relat
jejunoil
bypass
unusu
howev
patient
surgeri
decad
ago
may
present
endstag
liver
diseas
occas
refer
center
consider
liver
transplant
rare
nonalcohol
steatohepat
report
follow
gastric
partit
surgeri
numer
theori
propos
explain
liver
injuri
associ
jejunoil
bypass
bypass
procedur
result
malabsorpt
number
nutrient
account
weightloss
effect
mani
associ
complic
earli
research
note
similar
fatti
infiltr
seen
patient
protein
malnutrit
patient
jejunoil
bypass
serum
level
essenti
amino
acid
decreas
measur
period
rapid
weight
loss
concurr
increas
fatti
infiltr
liver
control
group
patient
stabl
weight
jejunoil
bypass
serum
amino
acid
level
higher
less
hepat
steatosi
nutrit
supplement
report
decreas
extent
hepat
injuri
patient
although
other
experienc
continu
deterior
anim
model
studi
patient
jejunoil
bypass
implic
bacteri
overgrowth
possibl
etiolog
factor
develop
hepat
steatosi
dog
model
jejunoil
bypass
vibramycin
treatment
prevent
appear
fatti
liver
death
liver
failur
rat
metronidazol
therapi
also
seem
amelior
postop
chang
liver
lesser
degre
protein
supplement
genet
obes
obob
mice
hepat
steatosi
shown
agerel
increas
product
endogen
ethanol
intestin
microflora
drenick
associ
treat
patient
metronidazol
administ
random
time
interv
jejunoil
bypass
untreat
patient
hepat
lipid
content
measur
morpholog
assess
elev
remain
abnorm
period
patient
patient
treat
metronidazol
hepat
fat
content
initi
elev
follow
bypass
surgeri
decreas
drug
start
anoth
group
metronidazol
administ
intermitt
level
hepat
fat
increas
decreas
concert
antibiot
therapi
moreov
studi
correl
hepat
steatosi
protein
malnutrit
mechan
hepat
injuri
although
perhap
relat
bacteri
overgrowth
remain
unknown
hepat
histolog
found
patient
undergon
jejunoil
bypass
often
resembl
chang
seen
alcohol
liver
diseas
common
find
includ
macrovesicular
steatosi
mallori
hyalin
sinusoid
fibrosi
infiltr
polymorphonuclear
leukocyt
histolog
chang
hepat
steatosi
often
worst
first
year
surgeri
may
improv
patient
other
show
continu
progress
cirrhosi
liver
failur
vyberg
cowork
perform
serial
liver
biopsi
morbidli
obes
patient
undergo
jejunoil
bypass
postop
patient
minim
histolog
chang
remaind
vari
degre
steatosi
steatohepat
perivenular
fibrosi
five
month
postop
liver
biopsi
reveal
progress
hepat
injuri
almost
patient
group
patient
minim
preoper
chang
develop
moder
mark
steatosi
patient
sever
chang
preoper
show
increas
steatohepat
fibrosi
develop
bridg
fibrosi
chang
cirrhosi
mallori
hyalin
seen
almost
onethird
patient
nasrallah
colleagu
attempt
identifi
preand
postop
variabl
may
predict
histolog
liver
injuri
jejunoil
bypass
preoper
morbidli
obes
patient
normal
liver
histolog
correl
preoper
histolog
serum
biochem
paramet
use
small
amount
alcohol
amount
weight
loss
postop
histolog
chang
liver
injuri
jejunoil
bypass
may
rang
asymptomat
elev
serum
hepat
enzym
cirrhosi
liver
failur
estim
patient
die
liver
failur
follow
procedur
liver
injuri
may
becom
clinic
appar
within
month
surgeri
progress
insidi
year
present
sign
symptom
cirrhosi
requarth
cowork
report
longterm
morbid
follow
jejunoil
bypass
patient
followup
patient
develop
acut
liver
failur
actuari
probabl
cirrhosi
earli
stage
hepat
injuri
associ
jejunoil
bypass
liver
enzym
abnorm
correl
histolog
find
therefor
limit
valu
identifi
patient
risk
liver
failur
mild
elev
serum
aminotransferas
alkalin
phosphatas
level
may
occur
mani
patient
signific
histolog
chang
biochem
abnorm
serial
liver
biopsi
may
help
follow
progress
liver
diseas
overt
liver
failur
develop
elev
serum
bilirubin
fall
serum
albumin
prolong
prothrombin
time
evid
patient
trial
parenter
vitamin
k
administr
worthwhil
exclud
malabsorpt
contribut
caus
coagulopathi
patient
discov
progress
liver
injuri
may
benefit
revers
bypass
oper
one
seri
patient
cirrhosi
revers
bypass
reestablish
continu
small
intestin
seven
patient
surviv
least
year
surgeri
followup
liver
biopsi
show
histolog
improv
patient
decreas
steatosi
inflamm
obviou
chang
liver
histolog
two
patient
die
liver
failur
shortli
revers
procedur
patient
preoper
ascit
indic
decompens
occur
prognosi
poor
patient
alreadi
develop
decompens
cirrhosi
liver
transplant
may
therapeut
option
avail
improv
qualiti
life
prolong
surviv
gener
believ
jejunoil
bypass
revers
either
immedi
liver
transplant
one
avoid
takedown
jejunoil
bypass
patient
advanc
liver
diseas
prior
transplant
surgic
intervent
poorli
toler
jejunoil
bypass
revers
substanti
risk
recurr
steatosi
progress
liver
damag
allograft
patient
liver
biopsi
perform
regular
basi
posttranspl
period
detect
progress
liver
damag
morbid
obes
common
posttranspl
period
jejunoil
bypass
revers
allograft
abnorm
uncommon
despit
weight
gain
patient
connect
tissu
disord
system
lupu
erythematosu
sle
rheumatoid
arthriti
syndrom
scleroderma
may
clinic
biochem
evid
associ
liver
diseas
sever
liver
involv
rang
asymptomat
elev
serum
aminotransferas
cirrhosi
liver
failur
unusu
liver
lesion
nodular
regen
hyperplasia
report
increas
frequenc
patient
connect
tissu
disord
last
decad
numer
report
associ
chronic
hepat
c
infect
syndrom
excel
review
recent
publish
abraham
colleagu
provid
detail
review
hepat
manifest
autoimmun
rheumat
diseas
sle
autoimmun
disord
involv
skin
kidney
cardiovascular
system
central
nervou
system
strict
criteria
reflect
multiorgan
involv
establish
american
colleg
rheumatolog
order
diagnos
sle
uniformli
distinguish
connect
tissu
disord
patient
requir
four
criteria
diagnosi
sle
establish
criteria
need
present
one
time
may
develop
sequenti
mani
year
liver
test
abnorm
part
diagnost
criteria
liver
gener
major
target
endorgan
damag
patient
sle
nevertheless
mani
patient
sle
may
clinic
signific
liver
diseas
runyon
associ
review
patient
met
criteria
sle
twentyon
percent
patient
abnorm
liver
enzym
point
ill
elev
could
usual
attribut
nonhepat
etiolog
comorbid
condit
patient
first
liver
enzym
elev
note
exacerb
sle
elev
aminotransferas
alkalin
phosphatas
level
usual
mild
less
fourfold
upper
limit
normal
howev
sever
liver
diseas
occur
approxim
patient
abnorm
liver
enzym
jaundic
patient
die
liver
failur
liver
biopsi
specimen
avail
patient
reveal
varieti
hepat
lesion
includ
nonspecif
portal
inflamm
chronic
activ
hepat
establish
cirrhosi
common
find
hepat
steatosi
seen
onethird
patient
autopsi
studi
publish
matsumoto
associ
studi
liver
specimen
clinic
data
patient
sle
none
patient
die
result
liver
failur
onethird
patient
abnorm
least
two
differ
liver
enzym
common
find
hepat
congest
although
author
felt
lesion
like
result
termin
event
previou
studi
hepat
steatosi
common
found
patient
twelv
percent
patient
chronic
hepat
interest
patient
histolog
evid
arter
find
previous
consid
rare
patient
sle
hepat
infarct
occur
patient
nodular
regen
hyperplasia
lesion
character
diffus
nodular
absenc
associ
fibrosi
seen
patient
hemophagocyt
syndrom
hp
seen
patient
sle
hp
clinicopatholog
entiti
character
system
prolifer
benign
hemophagocyt
cell
monocytemacrophagehistiocyt
lineag
character
fever
cytopenia
liver
dysfunct
lymphadenopathi
complic
develop
nearli
patient
sle
seen
yokohama
citi
univers
hospit
period
interpret
studi
liver
diseas
patient
sle
complic
comorbid
condit
potenti
drug
toxic
may
mimic
chronic
liver
diseas
abovement
studi
perform
prior
avail
hepat
c
test
thu
hepat
c
viru
hcv
exclud
caus
liver
enzym
elev
abnorm
hepat
histolog
particularli
import
sinc
substanti
number
patient
sle
receiv
blood
transfus
prior
addit
patient
studi
receiv
vari
dose
prednison
could
explain
frequent
find
hepat
steatosi
patient
hepat
injuri
salicyl
may
also
factor
produc
liver
dysfunct
associ
sle
connect
tissu
disord
salicylateinduc
hepatotox
appear
dosedepend
hepat
injuri
evid
dose
less
gday
blood
salicyl
level
mgdl
furthermor
correl
blood
salicyl
level
serum
alt
activ
featur
hypersensit
reaction
fever
rash
usual
absent
elev
liver
enzym
reflect
hepatocellular
injuri
elev
serum
aminotransferas
sometim
exceed
ul
discontinu
aspirin
result
prompt
improv
liver
enzym
chronic
sequela
ascit
report
sever
patient
sle
absenc
liver
diseas
secondari
condit
pathogenesi
ascit
patient
due
seros
associ
weep
lymphat
ascit
may
present
even
sle
rel
quiescent
symptom
sign
diseas
inact
increas
immunosuppress
prednison
may
benefici
reduc
slerel
ascit
etiolog
care
exclud
elev
alkalin
phosphatas
frequent
report
liver
test
abnorm
associ
rheumatoid
arthriti
may
seen
mani
patient
serum
aminotransferas
level
usual
normal
sourc
alkalin
phosphatas
bone
versu
liver
somewhat
controversi
studi
alkalin
phosphatas
fraction
almost
onethird
patient
rheumatoid
arthriti
elev
level
hepatobiliari
alkalin
phosphatas
suggest
liver
involv
howev
serum
enzym
gglutamyltranspeptidas
often
use
supplementari
assay
support
hepat
origin
alkalin
phosphatas
frequent
normal
patient
rheumatoid
arthriti
furthermor
enzym
shown
higher
level
joint
space
serum
impli
may
origin
inflam
joint
investig
demonstr
degre
total
alkalin
phosphatas
elev
vari
number
joint
involv
final
pattern
alkalin
phosphatas
fraction
may
vari
time
thu
abnorm
serum
liverassoci
enzym
patient
rheumatoid
arthriti
must
interpret
caution
number
liver
diseas
report
patient
adult
juvenil
rheumatoid
arthriti
tabl
ruderman
associ
publish
autopsi
studi
hepat
histolog
patient
rheumatoid
arthriti
common
find
hepat
congest
although
like
lesion
result
termin
event
sle
hepat
steatosi
common
found
patient
eleven
percent
patient
fibrosi
establish
cirrhosi
evid
amyloidosi
disord
describ
associ
rheumatoid
arthriti
primari
biliari
cirrhosi
pbc
nodular
regen
hyperplasia
seen
seri
nodular
regen
hyperplasia
report
associ
rheumatoid
arthriti
often
felti
syndrom
activ
joint
diseas
figur
featur
portal
hypertens
varic
ascit
common
latter
group
patient
pathogenesi
nodular
regen
hyperplasia
known
although
author
suggest
relat
drug
toxic
underli
portal
venou
thrombos
latter
hypothesi
intrigu
given
frequenc
antiphospholipid
syndrom
ap
patient
connect
tissu
diseas
popul
increas
incid
nodular
regen
hyperplasia
sle
drug
toxic
particularli
aspirin
salicyl
may
play
role
liver
abnorm
associ
rheumatoid
arthriti
gold
therapi
may
caus
intrahepat
cholestasi
featur
hypersensit
reaction
includ
skin
rash
eosinophilia
prolong
highdos
gold
salt
therapi
also
report
patient
produc
doserel
form
toxic
character
jaundic
sever
hepatocellular
necrosi
liver
biopsi
reveal
submass
hepat
necrosi
lobular
portal
inflamm
brownblack
pigment
identifi
gold
granul
seen
macrophag
electron
microscopi
demonstr
gold
particl
lysosom
believ
hepat
injuri
occur
concentr
gold
exceed
lysosom
storag
capac
perhap
controversi
issu
drug
therapi
hepatotox
involv
use
methotrex
treatment
rheumatoid
arthriti
topic
review
elsewher
chapter
ap
character
presenc
antiphospholipid
antibodi
anticardiolipin
antibodi
andor
lupu
anticoagul
associ
venousarteri
thrombos
recurr
fetal
loss
thrombocytopenia
although
ap
primari
disord
frequent
seen
patient
sle
connect
tissu
disord
commonli
describ
hepat
manifest
ap
buddchiari
syndrom
syndrom
autoimmun
disord
mainli
affect
exocrin
gland
usual
present
persist
dryness
mouth
eye
due
function
impair
salivari
lacrim
gland
pbc
common
primari
secondari
form
syndrom
studi
patient
primari
syndrom
patient
elev
antimitochondri
antibodi
titer
elev
alkalin
phosphatas
liver
biopsi
reveal
chang
earli
pbc
even
mani
patient
normal
liver
enzym
last
decad
numer
investig
explor
relationship
hcv
syndrom
haddad
colleagu
postul
causal
relationship
syndrom
hcv
report
preval
hcv
patient
syndrom
depend
method
detect
popul
studi
criteria
diagnos
primari
syndrom
european
patient
preval
rang
thirdgener
enzymelink
immunosorb
assay
secondgener
immunoblot
method
wherea
hcv
preval
american
patient
hcv
preval
much
lower
polymeras
chain
reaction
method
use
detect
hcv
object
criteria
appli
defin
primari
syndrom
base
current
evid
hcv
seem
rare
caus
primari
syndrom
except
patient
liver
involv
cryoglobulinemia
furthermor
hcv
sialotrop
viru
morpholog
evid
sialaden
found
signific
proport
patient
chronic
hcv
infect
hcvrelat
sialaden
lymphocyt
infiltr
predominantli
pericapillari
unlik
periduct
primari
syndrom
clinic
symptom
dryness
infrequ
reynold
colleagu
describ
patient
typic
pbc
vari
featur
scleroderma
crest
syndrom
calcinosi
raynaud
phenomenon
esophag
dysmotil
sclerodactyli
telangiectasia
sinc
associ
two
autoimmun
disord
well
establish
close
immunolog
associ
pbc
scleroderma
support
find
posit
antimitochondri
antibodi
onequart
patient
scleroderma
anticentromer
antibodi
onequart
patient
pbc
recent
studi
patient
system
local
scleroderma
liver
biopsyconfirm
pbc
seen
patient
sometim
patient
pbc
develop
symptomatolog
consist
scleroderma
review
patient
pbc
found
symptom
crest
syndrom
clinic
manifest
crest
often
anted
develop
pbc
much
year
rey
syndrom
acut
ill
character
encephalopathi
fatti
infiltr
liver
first
report
rey
colleagu
describ
australian
children
develop
loss
conscious
vomit
fever
hypoglycemia
occur
shortli
viral
prodrom
patient
seri
die
autopsi
extens
fatti
infiltr
note
liver
kidney
lesser
extent
myocardium
pancrea
center
diseas
control
cdc
defin
case
rey
syndrom
one
acut
noninflammatori
encephalopathi
manifest
clinic
alter
level
conscious
document
result
avail
measur
fewer
leukocyt
per
cubic
millimet
cerebrospin
fluid
presenc
cerebr
edema
without
perivascular
mening
inflamm
histolog
section
brain
hepatopathi
document
liver
biopsi
autopsi
threefold
greater
rise
ast
alt
serum
ammonia
reason
explan
cerebr
hepat
abnorm
figur
similar
declin
incid
rey
syndrom
note
uk
elsewher
figur
sinc
origin
descript
rey
syndrom
epidemiolog
studi
suggest
associ
rey
syndrom
use
aspirin
influenza
varicella
viral
infect
incid
rey
syndrom
higher
year
epidem
influenza
b
year
epidem
influenza
associ
found
subsequ
patient
develop
rey
syndrom
much
like
receiv
salicyl
prodrom
ill
develop
syndrom
previou
studi
cdc
odd
ratio
develop
rey
syndrom
associ
viral
ill
treat
aspirin
children
chronic
treat
salicyl
ill
juvenil
rheumatoid
arthriti
kawasaki
diseas
also
increas
risk
rey
syndrom
base
upon
observ
aspirin
aspirincontain
medic
label
advisori
administ
children
flulik
ill
declin
incid
rey
syndrom
usa
uk
tempor
associ
public
health
warn
risk
rey
syndrom
use
aspirin
children
varicella
influenzalik
ill
countri
aspirin
inadvert
use
children
viral
ill
rey
syndrom
continu
signific
problem
erron
diagnosi
rey
syndrom
uncommon
presumpt
criteria
use
establish
diagnosi
sever
inherit
metabol
disord
present
sign
symptom
indistinguish
rey
syndrom
see
chart
patient
origin
diagnos
rey
syndrom
blindli
review
one
case
felt
truli
due
rey
syndrom
uk
patient
origin
report
rey
syndrom
subsequ
diagnos
inherit
metabol
disord
rey
syndrom
rare
suggest
infant
children
suspect
disord
undergo
investig
exclud
presenc
inborn
metabol
disord
mimic
rey
syndrom
liver
specimen
patient
rey
syndrom
exhibit
sever
characterist
histolog
abnorm
figur
microvesicular
steatosi
decreas
absent
glycogen
store
common
appear
correl
sever
ill
surviv
minim
hepatocellular
necrosi
associ
lesion
hepat
glycogen
content
biopsi
taken
within
hour
onset
encephalopathi
significantli
lower
patient
die
lesion
also
appear
evolv
time
serial
biopsi
specimen
glycogen
stain
microvesicular
steatosi
may
initi
worsen
improv
within
week
onset
encephalopathi
survivor
liver
biopsi
perform
month
clinic
improv
show
essenti
normal
histolog
indic
hepat
lesion
rey
syndrom
complet
revers
electron
microscop
studi
liver
rey
syndrom
also
demonstr
characterist
find
consist
presum
pathogenesi
diseas
ultrastructur
studi
shown
mitochondria
within
hepatocyt
children
rey
syndrom
swollen
irregularli
shape
expans
matrix
space
chang
also
regress
parallel
clinic
improv
excel
review
metabol
abnorm
seen
rey
syndrom
inherit
disord
publish
hyperammonemia
may
result
decreas
activ
enzym
involv
urea
cycl
carbamyl
phosphat
synthetas
ornithin
transcarbamylas
otc
due
damag
hepat
mitochondria
enzym
normal
found
predominantli
within
mitochondria
howev
patient
rey
syndrom
otc
activ
shift
cytosol
presum
due
damag
mitochondri
membran
decreas
level
enzym
activ
transient
correl
clinic
statu
patient
increas
nitrogen
load
due
muscl
breakdown
also
report
patient
rey
syndrom
contribut
profound
hyperammonemia
present
disord
metabol
fatti
acid
also
impair
patient
rey
syndrom
numer
intermedi
metabolit
abnorm
elev
liver
plasma
urin
patient
high
level
compound
believ
inhibit
mitochondri
enzym
involv
ureagenesi
gluconeogenesi
fatti
acid
oxid
salicyl
may
inhibit
mitochondri
enzym
involv
fatti
acid
oxid
may
explain
associ
drug
develop
rey
syndrom
furthermor
mice
infect
influenza
viru
potenti
inhibitori
effect
salicyl
mitochondri
fatti
acid
oxid
deleteri
effect
salicyl
mitochondri
structur
function
may
cytokinemedi
pretreat
ainterferon
amelior
salicylateinduc
damag
isol
rat
liver
mitochondria
rey
syndrom
predominantli
seen
young
children
adolesc
report
occur
infrequ
adult
belay
et
al
found
case
usa
involv
patient
year
age
older
ill
jamaican
vomit
sick
drug
toxic
valproic
acid
fialuridin
may
present
similar
chang
microvesicular
steatosi
sever
inborn
metabol
disord
often
present
sign
symptom
indistinguish
rey
syndrom
common
metabol
disord
mimick
rey
syndrom
mediumchain
acylcoenzym
dehydrogenas
defici
major
inherit
disord
specif
enzymat
defect
usual
becom
evid
age
year
disord
character
recurr
episod
presenc
similar
disord
sibl
frequent
hypoglycemia
cardiac
enlarg
muscl
weak
consist
distinguish
featur
rey
syndrom
electron
microscopi
ultrastructur
chang
liver
tissu
specif
prolifer
smooth
endoplasm
reticulum
peroxisom
presenc
enlarg
pleomorph
mitochondria
loss
dens
granul
enzymat
defect
rey
manifest
contrast
mitochondria
normal
size
appear
ill
begin
viral
prodrom
may
begin
resolv
within
sever
day
patient
present
intract
vomit
mental
statu
chang
rang
irrit
mild
encephalopathi
confus
disorient
may
progress
deep
coma
serum
aminotransferas
level
elev
much
time
upper
limit
normal
prothrombin
time
usual
prolong
serum
ammonia
elev
serum
bilirubin
level
almost
invari
normal
slightli
elev
jaundic
conspicu
absent
rey
syndrom
treatment
rey
syndrom
gener
support
care
attent
hypoglycemia
electrolyt
disturb
highconcentr
glucos
solut
requir
maintain
adequ
serum
glucos
level
neurolog
deterior
consider
given
intracrani
pressur
monitor
order
guid
effect
variou
intervent
hyperventil
mannitol
infus
may
use
decreas
intracrani
pressur
report
cdc
describ
outcom
case
rey
syndrom
report
nrsss
overal
case
fatal
rate
level
conscious
time
admiss
strong
predictor
death
mortal
rate
increas
stage
alert
wake
stage
patient
unarous
areflexia
fix
pupil
tabl
addit
age
year
serum
ammonia
concentr
mgdl
independ
predictor
mortal
residu
neurolog
deficit
report
patient
deficit
mild
sever
patient
serum
ammonia
mgdl
significantli
higher
risk
neurolog
complic
rel
risk
confid
interv
stauffer
syndrom
paraneoplast
syndrom
liver
test
abnorm
patient
renal
cell
carcinoma
first
describ
stauffer
earli
literatur
incid
patient
renal
cell
cancer
rang
true
incid
difficult
ascertain
earli
report
due
inabl
adequ
exclud
hepat
metastas
caus
liver
test
abnorm
recent
studi
review
record
patient
renal
cell
carcinoma
paraneoplast
elev
alkalin
phosphatas
hepat
bone
metastas
exclud
comput
tomographi
scan
bone
scan
recent
evid
suggest
respons
caus
variou
paraneoplast
syndrom
seen
renal
cell
carcinoma
follow
evid
support
cytokin
involv
given
system
induc
find
similar
paraneoplast
syndrom
associ
renal
cell
carcinoma
fever
elev
alkalin
phosphatas
express
renal
cancer
cell
line
strong
correl
exist
serum
paraneoplast
elev
alkalin
phosphatas
administr
monoclon
antibodi
normal
alkalin
phosphatas
level
patient
stauffer
syndrom
strickland
schenker
review
publish
case
nephrogen
hepat
dysfunct
suffici
data
avail
appli
strict
criteria
diagnosi
fever
weight
loss
common
symptom
hepatomegali
present
twothird
patient
elev
alkalin
phosphatas
common
biochem
abnorm
occur
report
case
abnorm
serum
aminotransferas
serum
bilirubin
much
less
common
histolog
examin
liver
patient
nephrogen
hepat
dysfunct
shown
nonspecif
chang
steatosi
mild
focal
hepatocyt
necrosi
portal
lymphocyt
infiltr
kupffer
cell
hyperplasia
report
import
recogn
syndrom
lie
decis
concern
resect
tumor
differenti
benign
liver
enzym
abnorm
metastat
diseas
abnorm
hepat
function
usual
resolv
within
month
primari
tumor
resect
inde
import
featur
diagnosi
syndrom
recurr
renal
cell
carcinoma
clinic
biochem
characterist
nephrogen
hepat
dysfunct
may
becom
evid
hepat
involv
common
patient
system
amyloidosi
disord
abnorm
protein
deposit
variou
organ
histolog
examin
amyloid
protein
show
extracellular
amorph
eosinophil
hyalinelik
materi
materi
stain
congo
red
dye
show
applegreen
birefring
examin
polar
light
precursor
protein
although
vastli
differ
chemic
share
conform
properti
form
betapl
sheet
precipit
betapl
sheet
arrang
lead
characterist
histochem
find
amyloid
current
classifi
place
front
abbrevi
precursor
protein
tabl
least
differ
variant
mani
occur
focal
age
tumor
organ
directli
involv
liver
primari
al
amyloidosi
relat
deposit
immunoglobulin
lightor
heavychain
protein
probabl
common
form
system
amyloidosi
countri
immunoglobulin
normal
compon
humor
immun
system
normal
found
serum
ratio
kappa
lambda
lymphoplasmocyt
disord
multipl
myeloma
macroglobulinemia
overproduct
portion
immunoglobulin
molecul
gener
light
chain
lightchain
protein
breakdown
product
precipit
serum
form
amyloid
patient
amyloidosi
precipit
lambda
light
chain
suggest
form
like
produc
betapl
sheet
arrang
aa
secondari
amyloid
associ
chronic
infect
osteomyel
tuberculosi
cytokin
associ
inflamm
tumor
necrosi
factor
stimul
liver
produc
serum
amyloid
protein
injuryspecif
compon
highdens
lipoprotein
normal
human
aa
protein
exist
three
isoform
code
three
gene
short
arm
chromosom
protein
continu
produc
chronic
infect
peopl
vari
greatli
abil
clear
protein
individu
cleav
amyloid
small
peptid
patient
cleav
larger
size
consist
amyloid
subunit
famili
mediterranean
fever
fmf
autosom
recess
disord
associ
recurr
episod
fever
arthriti
seros
skin
rash
predominantli
seen
nonashkenazi
jewish
turkish
peopl
patient
develop
renal
diseas
ultim
renal
failur
prevent
colchicin
administr
recent
genet
defect
locat
short
arm
chromosom
patient
fmf
defect
occur
gene
code
protein
known
pyrinmarenostrin
unclear
gene
product
interact
serum
protein
produc
amyloidosi
mutat
transthyretin
gene
associ
famili
amyloidot
polyneuropathi
fap
common
type
herit
amyloidosi
transthyretin
gene
product
normal
serum
protein
larg
produc
liver
carri
serum
thyroxin
retinalbind
protein
protein
tetram
ident
subunit
encod
singl
gene
chromosom
least
differ
amino
acid
substitut
occur
differ
site
transthyretin
gene
report
mutat
amyloidogen
although
inherit
autosom
domin
disord
symptom
gener
aris
third
fourth
decad
life
disord
seen
portug
sweden
japan
usa
us
kindr
usual
exhibit
defect
associ
countri
origin
clinic
onset
quit
variabl
among
ethnic
group
even
patient
mutat
patient
usual
present
lowerlimb
nephropathi
progress
upper
limb
autonom
nervou
system
involv
also
usual
extens
often
result
diarrhea
chang
joint
skin
cornea
also
present
rare
organ
involv
patient
undergo
chronic
hemodialysi
develop
amyloid
secondari
precipit
b
microglobulin
protein
b
microglobulin
normal
serum
protein
hemodialysi
thought
produc
local
excess
concentr
precursor
result
deposit
amyloid
gener
musculoskelet
system
kidney
involv
although
amyloid
rel
homogen
appear
clear
etiolog
quit
variabl
mechan
amyloid
format
likewis
complex
probabl
variou
mechan
work
depend
type
amyloid
instanc
fap
disord
thought
inherit
mutat
caus
betapl
sheettyp
fibril
form
upon
normal
proteolysi
contrast
secondari
amyloidosi
overexpress
aa
protein
perhap
abnorm
proteolysi
result
deposit
fibril
amyloidosi
present
renal
dysfunctionren
failur
heart
failurecardiomyopathi
peripher
neuropathi
skin
rash
blood
dyscrasia
common
find
relat
liver
hepatomegali
sever
form
present
hepat
amyloidosi
summar
tabl
jaundic
cholestasi
one
initi
manifest
hepat
amyloidosi
present
omin
find
suggest
short
surviv
time
amyloid
also
present
catastroph
liver
failur
hepat
ruptur
ascit
due
sinusoid
occlus
also
present
symptom
gener
transaminas
minim
elev
although
quit
high
rare
case
fulmin
failur
jaundic
also
infrequ
except
rare
cholestat
case
imag
studi
may
show
infiltr
process
gener
help
gaug
extent
diseas
demonstr
amyloid
deposit
gener
requir
make
diagnosi
fat
pad
aspir
easiest
common
approach
diagnos
amyloidosi
neg
rectal
skin
biopsi
obtain
final
biopsi
affect
organ
need
amyloid
deposit
liver
occur
three
basic
pattern
common
pattern
protein
deposit
space
diss
figur
materi
accumul
encroach
hepatocyt
caus
extens
atrophi
amyloid
increas
mass
liver
produc
hepatomegali
rare
compromis
sinusoid
blood
flow
lead
portal
hypertens
anoth
pattern
deposit
amyloid
wall
hepat
arteriol
third
pattern
globular
cluster
amyloid
space
diss
latter
pattern
appear
uncommon
congo
red
stain
mainstay
diagnosi
commonli
use
diagnost
test
congo
red
stain
difficult
perform
correctli
characterist
stain
highli
depend
ph
salt
concentr
thick
materi
stain
variat
paramet
greatli
affect
qualiti
stain
congo
red
stain
rel
specif
amyloid
properli
perform
howev
condit
one
also
see
stain
fibrin
elastin
collagen
howev
usual
birefring
polar
light
stain
properti
congo
red
relat
betapl
sheet
arrang
protein
gener
type
amyloid
stain
congo
red
dye
howev
patient
al
amyloid
may
difficult
obtain
satisfactori
stain
reaction
case
may
use
attempt
stain
thioflavin
crystal
violet
methyl
violet
electron
microscopi
gold
standard
detect
amyloidosi
ultrastructur
examin
show
nonbranch
fibrillar
structur
indefinit
length
width
approxim
nm
therapi
gener
direct
treat
underli
condit
case
primari
amyloid
therapi
direct
underli
lymphoplasmocyt
neoplasm
sometim
improv
surviv
liver
transplant
perform
disord
shortterm
survivor
note
stem
cell
transplant
therapi
also
employ
mix
result
howev
gener
diseas
progress
fatal
complic
cardiac
renal
failur
eventu
ensu
case
amyloidosi
due
chronic
infect
erad
underli
infect
attempt
colchicin
treatment
choic
patient
fmf
orthotop
liver
transplant
success
patient
fap
center
recommend
transplant
patient
fap
soon
symptom
occur
liver
transplant
shown
diminish
diseas
progress
gener
littl
improv
autonom
dysfunct
alreadi
establish
patient
advanc
diseas
includ
upper
lower
motor
neuron
symptom
gener
poorli
patient
sicklecel
anemia
may
varieti
hepat
abnorm
involv
hepat
parenchyma
biliari
tract
abnorm
may
present
asymptomat
phase
sicklecel
diseas
well
episod
sickl
crisi
incid
hepat
involv
difficult
estim
due
confound
effect
chronic
hemolysi
may
elev
serum
bilirubin
aminotransferas
activ
consecut
patient
seen
outpati
inpati
univers
hospit
one
chronic
abnorm
liver
test
vast
major
abnorm
due
concurr
ill
rang
chronic
viral
hepat
congest
heart
failur
similarli
anoth
seri
serum
alkalin
phosphatas
abnorm
patient
sicklecel
diseas
although
appear
alkalin
phosphatas
mostli
bone
origin
thu
true
incid
hepat
involv
greatli
depend
upon
criteria
use
defin
liver
diseas
popul
hepat
crisi
sicklecel
diseas
character
right
upper
quadrant
abdomin
pain
jaundic
hepatomegali
fever
constel
find
also
suggest
acut
cholecyst
cholang
differenti
entiti
may
difficult
estim
hospit
sicklecel
anemia
complic
hepat
crise
mark
serum
biochem
abnorm
hepat
crisi
elev
serum
bilirubin
total
bilirubin
usual
less
mgdl
although
extrem
level
hyperbilirubinemia
greater
mgdl
may
occur
mark
hyperbilirubinemia
may
necessarili
associ
wors
prognosi
larg
compon
bilirubin
direct
fraction
may
much
total
bilirubin
mani
case
serum
aminotransferas
abnorm
level
usual
less
time
upper
limit
normal
elev
serum
ldh
activ
disproportion
increas
serum
aminotransferas
also
common
reflect
ongo
hemolysi
associ
sickl
crisi
evid
extrahepat
sickl
crisi
joint
flank
pain
usual
invari
present
gener
support
care
clinic
improv
seen
within
sever
day
although
hyperbilirubinemia
may
persist
sever
week
death
relat
fulmin
hepat
failur
absenc
identifi
etiolog
report
recent
data
suggest
acut
hepatopathi
due
sicklecel
anemia
consid
contraind
percutan
liver
biopsi
patient
sicklecel
diseas
percutan
liver
biopsi
seriou
hemorrhag
die
due
bleed
complic
bleed
complic
acut
sickl
crisi
time
liver
biopsi
pigment
gallston
frequent
found
patient
sicklecel
anemia
estim
preval
rang
incid
vari
directli
age
patient
choledocholithiasi
found
patient
undergo
cholecystectomi
hepat
crisi
resolv
quickli
support
care
cholecyst
cholang
ultim
requir
endoscop
andor
surgic
intervent
therefor
establish
correct
diagnosi
especi
import
suggest
oper
complic
cholecystectomi
patient
sicklecel
anemia
greater
gener
popul
schubert
review
publish
report
patient
underw
cholecystectomi
found
patient
complic
deem
seriou
includ
pneumonia
seizur
sickl
crisi
thu
cholecystectomi
reserv
patient
document
gallston
whose
symptom
clearli
biliari
tract
origin
hepat
crisi
biliari
tract
diseas
adequ
differenti
care
preoper
manag
special
attent
transfus
requir
volum
statu
import
expect
larg
number
transfus
requir
mani
patient
sicklecel
anemia
viral
hepat
report
occur
although
publish
report
incid
difficult
determin
patient
liver
test
abnorm
incid
hepat
b
viru
hbv
histolog
chang
chronic
hepat
rang
report
preval
hepat
c
patient
sicklecel
anemia
surprisingli
risk
hepat
c
directli
relat
number
transfus
receiv
impact
hepat
c
infect
natur
histori
patient
sicklecel
anemia
current
unknown
sever
studi
evalu
histopatholog
chang
liver
patient
sicklecel
diseas
studi
includ
biopsi
patient
hepat
crisi
well
biopsi
quiescent
period
hepat
sinusoid
distent
erythrocyt
sickl
erythrophagocytosi
found
almost
patient
figur
studi
pregnant
women
given
prophylact
red
cell
transfus
erythrocyt
sickl
erythrophagocytosi
present
patient
absenc
hepat
crisi
thu
chang
appear
characterist
sicklecel
anemia
correl
aminotransferas
level
activ
liver
diseas
presenc
histolog
lesion
may
also
detect
liver
patient
sicklecel
anemia
confus
clinic
pictur
massiv
iron
deposit
frequent
identifi
routin
iron
stain
major
patient
also
patient
sicklecel
anemia
biopsi
perform
abnorm
liver
test
chang
consist
acut
chronic
viral
hepat
cirrhosi
report
occur
patient
sicklecel
anemia
may
due
hypox
injuri
sickl
intrasinusoid
sludg
erythrocyt
chronic
viral
hepat
massiv
hemosiderosi
hepat
involv
hodgkin
lymphoma
report
occur
patient
time
diagnosi
cours
diseas
time
autopsi
histolog
liver
involv
malign
lymphoma
review
extent
tissu
sampl
correl
abil
stage
hepat
involv
hodgkin
diseas
accur
percutan
liver
biopsi
lowest
yield
laparoscopi
laparotomi
similar
yield
diagnosi
hepat
involv
hodgkin
diseas
requir
find
reedsternberg
cell
figur
nonspecif
inflammatori
infiltr
seen
liver
biopsi
patient
hodgkin
diseas
alon
constitut
ground
diagnos
hepat
involv
noncas
epithelioid
granuloma
may
seen
patient
hodgkin
diseas
granuloma
may
seen
portal
tract
hepat
lobul
necessarili
indic
hepat
involv
hodgkin
diseas
elev
serum
alkalin
phosphatas
level
frequent
abnorm
liver
test
found
patient
hodgkin
diseas
review
inpati
hodgkin
diseas
abnorm
serum
alkalin
phosphatas
level
patient
advanc
stage
hodgkin
diseas
like
elev
enzym
patient
stage
ii
diseas
patient
stage
iii
stage
iv
diseas
respect
abnorm
serum
alkalin
phosphatas
level
elev
gener
mild
time
upper
limit
normal
although
mark
increas
note
patient
stage
iv
diseas
liver
felt
sourc
alkalin
phosphatas
major
patient
although
sever
patient
adolesc
potenti
bone
growth
elev
bone
fraction
abnorm
alkalin
phosphatas
seen
sever
patient
absenc
hepat
involv
commonli
patient
fever
system
manifest
hodgkin
diseas
thu
patient
abnorm
serum
alkalin
phosphatas
could
repres
equival
acutephas
respons
jaundic
occur
infrequ
hodgkin
lymphoma
except
late
stage
ill
frequent
caus
jaundic
intrahepat
infiltr
tumor
seen
jaundic
patient
time
autopsi
extrahepat
biliari
tract
obstruct
occur
much
less
frequent
account
jaundic
patient
small
number
patient
hodgkin
lymphoma
describ
evid
sever
intrahepat
cholestasi
dramat
elev
serum
bilirubin
alkalin
phosphatas
level
absenc
tumor
infiltr
bile
duct
obstruct
etiolog
syndrom
known
one
report
suggest
could
relat
vanish
bile
duct
syndrom
associ
primari
scleros
cholang
hodgkin
lymphoma
also
suggest
acut
liver
failur
encephalopathi
jaundic
coagulopathi
also
report
patient
hodgkin
nonhodgkin
lymphoma
either
due
direct
hepat
involv
paraneoplast
syndrom
hepat
involv
nonhodgkin
lymphoma
occur
frequent
estim
rang
hepat
infiltr
usual
involv
portal
triad
nodular
appear
figur
epithelioid
granuloma
may
also
seen
liver
patient
immunophenotyp
use
monoclon
antibodi
may
perform
snapfrozen
liver
biopsi
tissu
order
character
infiltr
rare
primari
hepat
lymphoma
absenc
system
lymphoma
report
clinic
manifest
hepat
infiltr
nonhodgkin
lymphoma
similar
seen
hodgkin
diseas
patient
may
remain
asymptomat
despit
extens
hepat
infiltr
mild
moder
elev
serum
alkalin
phosphatas
moder
mark
elev
ldh
activ
may
present
contrast
hodgkin
diseas
nonhodgkin
lymphoma
like
produc
jaundic
result
extrahepat
obstruct
usual
porta
hepati
rather
direct
hepat
infiltr
reactiv
chronic
hepat
b
patient
receiv
cytotox
therapi
well
document
recent
data
suggest
lamivudin
prevent
reactiv
hepat
b
patient
receiv
chemotherapi
report
suggest
hcv
may
role
develop
nonhodgkin
lymphoma
report
fail
confirm
associ
patient
lymphoma
sever
liver
dysfunct
due
either
lymphoma
involv
coexist
liver
problem
pose
signific
therapeut
problem
due
inabl
toler
convent
chemotherapeut
agent
ghobrial
colleagu
summar
experi
patient
seen
mayo
clinic
period
author
found
mechlorethamin
highdos
corticosteroid
rituximab
safe
effect
patient
popul
liver
may
directli
involv
plasma
cell
infiltr
patient
multipl
myeloma
patient
gener
present
hepatomegali
ascit
import
distinguish
myeloma
liver
involv
myeloma
autoimmun
hepat
myeloma
plasma
cell
infiltr
predominantli
involv
sinusoid
rel
spare
portal
tract
distinct
autoimmun
hepat
infiltr
predominantli
portal
area
anoth
pattern
liver
injuri
myeloma
patient
nodular
regen
hyperplasia
macroglobulinemia
neoplast
disord
blymphocyt
plasma
cell
allud
previous
neoplast
cell
secret
immunoglobulin
heavi
chain
rare
associ
develop
amyloidosi
lymphoplasmacyt
tumor
directli
involv
liver
clinic
liver
diseas
patient
often
mild
minim
elev
transaminas
alkalin
phosphatas
symptom
usual
refer
extrahepat
problem
associ
diseas
histolog
infiltr
show
expand
portal
tract
lymphocyt
plasma
cell
larger
atyp
cell
occasion
mitot
figur
mastocytosi
commonli
seen
children
skin
rash
urticaria
pigmentosa
howev
diseas
becom
system
involv
liver
especi
adult
patient
seen
adult
often
present
fever
hepatosplenomegali
steatorrhea
diarrhea
weight
loss
liver
chemistri
usual
minim
abnorm
radiolog
studi
often
contributori
liver
biopsi
demonstr
characterist
lesion
similar
seen
organ
includ
spleen
lymph
node
lesion
character
irregular
area
fibrosi
contain
numer
eosinophil
background
lymphocyt
mononuclear
cell
figur
mononuclear
cell
mast
cell
may
recogn
number
method
cell
often
degranul
toluidin
blue
stain
may
help
chloroacet
esteras
stain
howev
usual
diagnost
cell
also
exhibit
ckit
fibrot
cluster
may
locat
either
portal
tract
parenchyma
lesion
abut
central
vein
may
respons
rare
case
portal
hypertens
associ
diseas
sever
acut
respiratori
syndrom
sar
seriou
infecti
diseas
spread
via
airborn
droplet
result
sever
acut
pulmonari
inflamm
epitheli
damag
studi
confirm
novel
corona
viru
call
sar
corona
viru
scov
etiolog
agent
liver
test
abnorm
seen
patient
hospit
sar
common
liver
test
abnorm
mild
elev
serum
transaminas
transaminas
level
peak
second
week
ill
level
improv
success
recoveri
phenomenon
mildli
elev
transaminas
like
nonspecif
respons
sever
system
ill
hypoxemia
possibl
relat
multipl
medic
occasion
transaminas
level
may
significantli
elev
peak
alt
valu
rang
iul
chau
colleagu
describ
liver
histolog
patient
sar
markedli
elev
transaminas
evid
organ
failur
three
biopsi
hepatocyt
apoptosi
patient
mark
accumul
cell
mitosi
figur
liver
biopsi
also
exhibit
balloon
degener
hepatocyt
mild
moder
lymphocyt
infiltr
revers
transcriptas
polymeras
chain
reaction
posit
scov
liver
tissu
patient
suggest
pattern
liver
injuri
may
inde
repres
form
sarsassoci
viral
hepat
